Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Sales | 2,707 | 1,110 | 1,451 | 1,400 | 768 |
| Cost of Goods | 981 | 550 | 1,345 | 653 | 1,483 |
| Gross Profit | 1,726 | 560 | 106 | 747 | -715 |
| Operating Expenses | 4,525 | 4,288 | 3,589 | 4,603 | 4,709 |
| Operating Income | -1,818 | -3,178 | -3,138 | -3,203 | -4,941 |
| Interest Expense | -9 | 74 | 112 | 20 | 6 |
| Other Income | 206 | 318 | 335 | 487 | 605 |
| Pre-tax Income | -1,603 | -2,934 | -2,915 | -2,736 | -4,342 |
| Net Income Continuous | -1,603 | -2,934 | -2,915 | -2,736 | -4,342 |
| Net Income | $-1,603 | $-2,934 | $-2,915 | $-2,736 | $-4,342 |
| EPS Basic Total Ops | -0.11 | -0.20 | -0.20 | -0.18 | -0.29 |
| EPS Basic Continuous Ops | -0.11 | -0.20 | -0.20 | -0.18 | -0.29 |
| EPS Diluted Total Ops | -0.11 | -0.20 | -0.20 | -0.18 | -0.29 |
| EPS Diluted Continuous Ops | -0.11 | -0.20 | -0.20 | -0.18 | -0.29 |
| EBITDA(a) | $-1,448 | $-2,825 | $-2,792 | $-2,880 | $-4,652 |